Brca AND (genetic OR genomic) AND review - PubMed - NCBI

Brca AND (genetic OR genomic) AND review - PubMed - NCBI



From PubMed

PubMed comprises more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.

---

• PubMed links to genetics reviews articles for "Brca" 

Best matches for Brca AND (genetic OR genomic) AND review:

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.Baretta Z et al. Medicine (Baltimore). (2016)

Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Hoskins PJ et al. CA Cancer J Clin. (2017)

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Nelson HD et al. Ann Intern Med. (2014)

Search results

Items: 1 to 20 of 731

<< First< Prev

Page  of 37

Next >Last >>

Select item 304731251.

No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.

Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.

J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.

PMID:

 

30473125

Similar articles

Select item 304546792.

Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses.

Burdak-Rothkamm S, Rothkamm K.

Mutat Res. 2018 Oct - Dec;778:13-22. doi: 10.1016/j.mrrev.2018.08.001. Epub 2018 Aug 17. Review.

PMID:

 

30454679

Similar articles

Select item 304285473.

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.

McCuaig JM, Armel SR, Care M, Volenik A, Kim RH, Metcalfe KA.

Cancers (Basel). 2018 Nov 13;10(11). pii: E435. doi: 10.3390/cancers10110435. Review.

PMID:

 

30428547

 

Free PMC Article

Similar articles

Select item 304006474.

Population Based Testing for Primary Prevention: A Systematic Review.

Manchanda R, Gaba F.

Cancers (Basel). 2018 Nov 5;10(11). pii: E424. doi: 10.3390/cancers10110424. Review.

PMID:

 

30400647

 

Free PMC Article

Similar articles

Select item 303561385.

State-of-the-art strategies for targeting the DNA damage response in cancer.

Pilié PG, Tang C, Mills GB, Yap TA.

Nat Rev Clin Oncol. 2018 Oct 24. doi: 10.1038/s41571-018-0114-z. [Epub ahead of print] Review.

PMID:

 

30356138

Similar articles

Select item 303522496.

Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.

Younes N, Zayed H.

Gene. 2018 Oct 22;684:154-164. doi: 10.1016/j.gene.2018.10.044. [Epub ahead of print] Review.

PMID:

 

30352249

Similar articles

Select item 303519817.

Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives.

Fremd C, Jaeger D, Schneeweiss A.

Expert Rev Anticancer Ther. 2018 Oct 23:1-14. doi: 10.1080/14737140.2019.1537785. [Epub ahead of print]

PMID:

 

30351981

Similar articles

Select item 303454128.

Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in GenomeIntegrity and Cancer.

Chen CC, Feng W, Lim PX, Kass EM, Jasin M.

Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1.

PMID:

 

30345412

 

Free PMC Article

Similar articles

Select item 303057239.

Family-based germline sequencing in children with cancer.

Kuhlen M, Taeubner J, Brozou T, Wieczorek D, Siebert R, Borkhardt A.

Oncogene. 2018 Oct 10. doi: 10.1038/s41388-018-0520-9. [Epub ahead of print] Review.

PMID:

 

30305723

Similar articles

Select item 3029509110.

Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations.

Doren A, Vecchiola A, Aguirre B, Villaseca P.

Climacteric. 2018 Oct 8:1-7. doi: 10.1080/13697137.2018.1514006. [Epub ahead of print]

PMID:

 

30295091

Similar articles

Select item 3029371011.

The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.

Staropoli N, Ciliberto D, Del Giudice T, Iuliano E, Cucè M, Grillone F, Salvino A, Barbieri V, Russo A, Tassone P, Tagliaferri P.

Crit Rev Oncol Hematol. 2018 Nov;131:83-89. doi: 10.1016/j.critrevonc.2018.08.011. Epub 2018 Sep 3. Review.

PMID:

 

30293710

Similar articles

Select item 3027888312.

[DNA damage repair: An emerging strategy in metastatic prostate cancer].

Loriot Y, Meynard G, Klajer E, Bolognini C, Gassian N, Thiery-Vuillemin A.

Bull Cancer. 2018 Oct;105(10):944-954. doi: 10.1016/j.bulcan.2018.05.017. Epub 2018 Sep 29. Review. French.

PMID:

 

30278883

Similar articles

Select item 3024089813.

Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.

AlHilli MM, Al-Hilli Z.

J Minim Invasive Gynecol. 2018 Sep 19. pii: S1553-4650(18)31215-9. doi: 10.1016/j.jmig.2018.09.767. [Epub ahead of print] Review.

PMID:

 

30240898

Similar articles

Select item 3023132814.

Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer.

Pegram MD, Zong Y, Yam C, Goetz MP, Moulder SL.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):65-77. doi: 10.1200/EDBK_200715. Review.

PMID:

 

30231328

 

Free Article

Similar articles

Select item 3017824215.

Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.

Gleeson FC, Levy MJ.

Curr Treat Options Gastroenterol. 2018 Dec;16(4):441-448. doi: 10.1007/s11938-018-0195-x. Review.

PMID:

 

30178242

Similar articles

Select item 3017472516.

Surgery for BRCA, TP53 and PALB2: a literature review.

Song CV, Teo SH, Taib NA, Yip CH.

Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018. Review.

PMID:

 

30174725

 

Free PMC Article

Similar articles

Select item 3014635117.

Genetic Markers in Triple-Negative Breast Cancer.

Sporikova Z, Koudelakova V, Trojanec R, Hajduch M.

Clin Breast Cancer. 2018 Oct;18(5):e841-e850. doi: 10.1016/j.clbc.2018.07.023. Epub 2018 Aug 4. Review.

PMID:

 

30146351

 

Free Article

Similar articles

Select item 3013571718.

Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.

Frank S, Nelson P, Vasioukhin V.

F1000Res. 2018 Aug 2;7. pii: F1000 Faculty Rev-1173. doi: 10.12688/f1000research.14499.1. eCollection 2018. Review.

PMID:

 

30135717

 

Free PMC Article

Similar articles

Select item 3012884519.

Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs.

Diana A, Franzese E, Centonze S, Carlino F, Della Corte CM, Ventriglia J, Petrillo A, De Vita F, Alfano R, Ciardiello F, Orditura M.

Curr Oncol Rep. 2018 Aug 20;20(10):76. doi: 10.1007/s11912-018-0726-6. Review.

PMID:

 

30128845

Similar articles

Select item 3012871220.

Harnessing the Immune System in Pancreatic Cancer.

Das S, Berlin J, Cardin D.

Curr Treat Options Oncol. 2018 Aug 20;19(10):48. doi: 10.1007/s11864-018-0566-5. Review.

PMID:

 

30128712

Similar articles